Insulet Corporation
About
Insulet Corporation (NASDAQ:PODD) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 28 2026
Insulet to Participate in BofA Securities 2026 Health Care Conference
Apr 1 2026
Insulet to Announce First Quarter 2026 Financial Results on May 6, 2026
Mar 30 2026
Insulet Appoints Mike Panos as Chief Commercial Officer
Mar 12 2026
Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® 5 Pods in the U.S.
Mar 11 2026
Insulet Presents Promising Study Results for Fully Closed-Loop Automated Insulin Delivery System for Adults with Type 2 Diabetes
Recent Videos
2026/04/24 Insulet (PODD): A Long-term Goldmine Oversold by GLP-1 Fears
Apr 24, 2026
What is the Omnipod® Demo Pod* and how do you apply it?
Apr 23, 2026
PODD: Is Insulet's Diabetes Tech Moat Unbreakable?
Apr 07, 2026
Insulet OmniPod5 dolazi u Hrvatsku! ATTD2026
Mar 26, 2026
Financials
Revenue
$2.71 B
Market Cap
$14.38 B
P/E Ratio
58.88
EPS
3.47